Health

New Delhi [India], September 29: Heart disease is no longer a condition of the elderly—it is alarmingly affecting people in their 20s, 30s, and 40s. Sedentary lifestyles, stress, unhealthy diets, and late diagnoses are driving a surge in cardiac cases among the young. On this World Heart Day 2025, leading cardiologists share their insights, highlighting why timely awareness, early screening, and preventive action are critical to protecting heart health before it’s too late. 1. Prof. (Dr) M. Wali MD FRCP FACC (USA), Sir Ganga Ram Hospital, New Delhi Padma Shri Dr. Mohsin Wali, a distinguished cardiologist, stands as one of the most respected figures in Indian medicine. His remarkable journey began with the rare honor of becoming the youngest physician to serve an Indian President. Over the ...

New Delhi [India], September 29: Heart disease is no longer just a concern for older adults—it is increasingly affecting young people in their 20s, 30s, and 40s. Sedentary lifestyles, stress, unhealthy diets, and delayed diagnosis are driving this alarming trend. On this World Heart Day 2025, leading cardiologists emphasise the importance of awareness, early detection, and preventive measures, highlighting why waiting for symptoms can be extremely dangerous. 1. Prof. Dr C.V. Bhirmanandham MD (Medicine), DM (Cardiology), MAMS (Cardiology), D.Sc. (Cardiology), FRSTM (London), FCCP (USA), FICA (USA) Prof. Dr C.V. Bhirmanandham, Senior Consultant Cardiologist at Apollo Hospitals, Chennai, and former Professor and Chief Cardiologist at Madras Medical College, has dedicated his career to advanci...

Hyderabad (Telangana) [India], September 27: Apollo Hospitals, one of Asia’s largest and most trusted healthcare providers, has signed a strategic agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. Apollo Hospitals has signed an agreement to provide advanced medical care to Iraq’s security forces and their families, further strengthening India’s healthcare footprint overseas. Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, said the partnership is in line with the vision of “Heal in India, Heal by India, Heal from India.” “Over the years, Apollo Hospitals, Hyderabad, has emerged as a global hub for healthcare. Every month, more than 20,000 international patients are treated here. This agreement reinforces our m...

New Delhi [India], September 27: In the heart of Anand, a city known for Amul and its role in India’s White Revolution, a young boy was learning lessons that would shape his life. Born on 27 December 1989, Niket Patel grew up in a family where medicine was everywhere. His father, Dr Hitesh Patel, and mother, Dr Nayna Patel, often discussed patients at the dinner table. His sister, Dr Mitali Patel, and later his wife, Dr Molina Patel, also chose medicine, making it a family passion. Little did Anand know that this boy would bring hope to thousands. Niket’s school days at Anandalaya Education Society were filled with lessons on discipline, kindness, and helping others. Even then, he showed curiosity about health and care. Then, Niket continued his studies at Pramukhswami Medical College in K...

New Delhi [India], September 27: In a significant development for India’s animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA). VVIMA is a non-government, not-for-profit organization that will serve as the collective voice of India’s veterinary vaccine manufacturers. The association will actively collaborate with policymakers, regulators, and stakeholders to shape an enabling ecosystem for innovation, quality manufacturing, and global competitiveness in veterinary vaccines. It envisions positioning India as a global hub for the research, development, and production of animal vaccines. VVIMA members with Secretary Mr. Naresh Pal Gangwar, Department of Animal Husbandry & Dairy...

Hyderabad (Telangana) [India], September 25: Nearly 50% of Indian women aged between 35 and 49 years are now classified as overweight or obese, according to a recent study reported by The Times of India. The findings raise critical questions about women’s reproductive health and fertility outcomes, especially as more couples in urban India turn to assisted reproductive technologies (ART) like IVF. Dr. S. Vyjayanthi, internationally renowned Fertility Specialist and Director of MotherToBe Fertility Centre, explains that obesity has a direct and multi-faceted impact on reproductive health. “Obesity affects ovulation, egg quality, and even the receptivity of the uterus. Women with higher body mass index (BMI) often face irregular menstrual cycles, higher prevalence of PCOS, and lower IVF succ...

Hyderabad (Telangana) [India], September 25:  Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. One procedure leading this change is egg freezing, and guiding this shift with expertise and compassion is Dr S. Vyjayanthi, Director of MotherToBe Fertility Centre and Head of the Fertility Department at KIMS Hospitals, Secunderabad. The Changing Face of Fertility Choices Traditionally, fertility treatments were sought only when couples encountered challenges conceiving. But today, women in their late 20s and early 30s are taking a proactive step by choosing to freeze their eggs. According to Dr Vyjayanthi, this marks a new era in reproductive health. “Egg freezing i...

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets Affordability Pertuzumab plays a vital role in the standard of care for HER2-positive breast cancer worldwide. By leveraging Enzene’s patented EnzeneX technology, Perzea becomes not only affordable but also reliable in terms of quality and production efficiency. This innovation-driven partnership sets new standard...

New Delhi [India], September 25: With breast cancer on the rise and 1 in 8 Indian women at risk, a landmark initiative blends knowledge, self-advocacy, and risk assessment to transform how India faces its most common women’s cancer. After winning international recognition for pioneering a breast cancer awareness program in South Africa, Phylaxis.ai® now brings an enhanced empowerment model to India – combining awareness and risk assessment for the first time. The Global and Indian Challenge: Why Empowerment Matters? Lack of medically correct awareness and not being conscious of an individual’s risk profile are the leading causes of late-detection breast cancer. Breast cancer has become the most common cancer among women in India, with more than 200,000 new cases every year, according to th...

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients. Bringing Advanced Cancer Care Within Reach Pertuzumab, a monoclonal antibody, is globally recognised as a HER2-positive breast cancer therapy when administered with trastuzumab and chemotherapy. Despite its proven efficacy, the high cost of treatment has restricted access in India. With Perzea, Hetero Healthcare is determined to change this reality, offering patie...